PNT logo

POINT Biopharma Global (PNT) Cash From Operations

Annual CFO

$183.52 M
+$228.22 M+510.57%

December 31, 2022

Summary

Performance

1-Year Change

+510.57%

3-Year Change

+2310.3%

5-Year Change

+2310.3%

15-Year Change

+2310.3%

PNT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$183.52 M
PNT annual cash flow from operations is currently at an all-time high

3-Year Low

-$44.70 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PNT previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PNT next annual earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

Annual CFI

-$266.26 M
PNT annual cash flow from investing activities is -$266.26 million

Annual CFF

$130.36 M
PNT annual cash flow from financing activities is $130.36 million

Annual FCF

$170.75 M
PNT annual free cash flow is $170.75 million

Annual CAPEX

$12.77 M
PNT annual capital expenditures is $12.77 million

Quarterly CFO

-$28.13 M
+$46.20 M+62.16%

September 30, 2023

Summary

Performance

3-Month Change

+62.16%

1-Year Change

-25.99%

3-Year Change

-

5-Year Change

-

PNT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$236.92 M
PNT quarterly cash flow from operations is currently -111.87% below its historical high of $236.92 million

3-Year Low

-$74.34 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PNT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PNT next earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

Quarterly CFI

-$7.40 M
PNT quarterly cash flow from investing activities is -$7.40 million

Quarterly CFF

-$152.30 K
PNT quarterly cash flow from financing activities is -$152.30 thousand

Quarterly FCF

-$34.53 M
PNT quarterly free cash flow is -$34.53 million

Quarterly CAPEX

$6.39 M
PNT quarterly capital expenditures is $6.39 million

TTM CFO

$112.06 M
-$5.80 M-4.92%

September 30, 2023

Summary

Performance

3-Month Change

-4.92%

1-Year Change

+272.59%

3-Year Change

-

5-Year Change

-

PNT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$183.52 M
PNT TTM cash flow from operations is currently -38.94% below its historical high of $183.52 million

3-Year Low

-$64.92 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PNT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PNT next earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

TTM CFI

-$229.73 M
PNT TTM cash flow from investing activities is -$229.73 million

TTM CFF

$13.50 M
PNT TTM cash flow from financing activities is $13.50 million

TTM FCF

$92.74 M
PNT TTM free cash flow is $92.74 million

TTM CAPEX

$19.32 M
PNT TTM capital expenditures is $19.32 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PNT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+510.6%-26.0%+272.6%
3 y3 years+2310.3%--
5 y5 years+2310.3%--

PNT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-124.4%-111.9%+164.2%-38.9%-157.9%
5 y5-yearat high-124.4%-111.9%+164.2%-38.9%-157.9%
alltimeall timeat high-124.4%-111.9%+164.2%-38.9%-157.9%

POINT Biopharma Global Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2023
-
-$28.13 M(-62.2%)
$112.06 M(-4.9%)
Jun 2023
-
-$74.34 M(+232.0%)
$117.86 M(-31.3%)
Mar 2023
-
-$22.39 M(-109.5%)
$171.62 M(-6.5%)
Dec 2022
$183.52 M
$236.92 M(-1161.1%)
$183.52 M(-382.7%)
Sep 2022
-
-$22.33 M(+8.5%)
-$64.92 M(+15.3%)
Jun 2022
-
-$20.58 M(+96.2%)
-$56.32 M(+27.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$10.49 M(-9.0%)
-$44.22 M(-1.1%)
Dec 2021
-$44.70 M(+438.4%)
-$11.53 M(-16.0%)
-$44.70 M(+34.8%)
Sep 2021
-
-$13.73 M(+61.9%)
-$33.17 M(+70.6%)
Jun 2021
-
-$8.48 M(-22.7%)
-$19.44 M(+77.3%)
Mar 2021
-
-$10.97 M
-$10.97 M
Dec 2020
-$8.30 M
-
-

FAQ

  • What is POINT Biopharma Global annual cash flow from operations?
  • What is the all time high annual CFO for POINT Biopharma Global?
  • What is POINT Biopharma Global annual CFO year-on-year change?
  • What is POINT Biopharma Global quarterly cash flow from operations?
  • What is the all time high quarterly CFO for POINT Biopharma Global?
  • What is POINT Biopharma Global quarterly CFO year-on-year change?
  • What is POINT Biopharma Global TTM cash flow from operations?
  • What is the all time high TTM CFO for POINT Biopharma Global?
  • What is POINT Biopharma Global TTM CFO year-on-year change?

What is POINT Biopharma Global annual cash flow from operations?

The current annual CFO of PNT is $183.52 M

What is the all time high annual CFO for POINT Biopharma Global?

POINT Biopharma Global all-time high annual cash flow from operations is $183.52 M

What is POINT Biopharma Global annual CFO year-on-year change?

Over the past year, PNT annual cash flow from operations has changed by +$228.22 M (+510.57%)

What is POINT Biopharma Global quarterly cash flow from operations?

The current quarterly CFO of PNT is -$28.13 M

What is the all time high quarterly CFO for POINT Biopharma Global?

POINT Biopharma Global all-time high quarterly cash flow from operations is $236.92 M

What is POINT Biopharma Global quarterly CFO year-on-year change?

Over the past year, PNT quarterly cash flow from operations has changed by -$5.80 M (-25.99%)

What is POINT Biopharma Global TTM cash flow from operations?

The current TTM CFO of PNT is $112.06 M

What is the all time high TTM CFO for POINT Biopharma Global?

POINT Biopharma Global all-time high TTM cash flow from operations is $183.52 M

What is POINT Biopharma Global TTM CFO year-on-year change?

Over the past year, PNT TTM cash flow from operations has changed by +$176.98 M (+272.59%)